Tyler Bussian

Stock Analyst at Brookline Capital

(1.88)

# 1,803

Out of 4,496 analysts

4

Total ratings

100%

Success rate

47.81%

Average return

Main Sectors:

Top Industries:

3 Stocks

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	CRVO CervoMed	Initiates: Buy	$63	$16.25	+287.69%	1	Jul 8, 2024
	IMUX Immunic	Initiates: Buy	$10	$1.41	+609.22%	1	Apr 5, 2024
	ANVS Annovis Bio	Downgrades: Hold	$9	$11.33	-20.56%	2	Feb 28, 2024

CervoMed

Jul 8, 2024

Initiates: Buy

Price Target: $63

Current: $16.25

Upside: +287.69%

Immunic

Apr 5, 2024

Initiates: Buy

Price Target: $10

Current: $1.41

Upside: +609.22%

Annovis Bio

Feb 28, 2024

Downgrades: Hold

Price Target: $9

Current: $11.33

Upside: -20.56%